Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma.
Journal Information
Full Title: Ann Surg Oncol
Abbreviation: Ann Surg Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: General Surgery
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosure Dr. James Harding. Research Support to Institution: Bristol Myers Squibb, Boehringer Ingelheim, CytomX, Debiopharm, Eli Lilly, Genoscience, Incyte, Loxo @ Lilly, Novartis, Polaris, Pfizer, Zymeworks, and Yiviva. Consulting/Advisory: Adaptimmune, Astrazenica, Bristol Myers Squibb, Exelexis, Elevar, Eisai, Genoscience (uncompensated), Hepion, Imvax, Merck (DSMB) Medivir, QED, Tyra, and Zymeworks (uncompensated)."
"Stijn Franssen received support from the Dutch Cancer Society (KWF) on project number 12077. Joshua Jolissaint received support from the Weill Cornell Medical College (WCMC). Clinical and Translational Science Center (CTSC) funded by NIH/NCATS UL1TR002384."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025